These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6219754)
1. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations. Chapes SK; Haskill S Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754 [TBL] [Abstract][Full Text] [Related]
2. Evidence for granulocyte-mediated macrophage activation after C. parvum immunization. Chapes SK; Haskill S Cell Immunol; 1983 Feb; 75(2):367-77. PubMed ID: 6831566 [TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth. Lee KC; Berry D J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353 [TBL] [Abstract][Full Text] [Related]
4. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice. Lichtenstein A; Tuttle R; Cantrell J; Zighelboim J J Natl Cancer Inst; 1982 Aug; 69(2):495-501. PubMed ID: 6213807 [TBL] [Abstract][Full Text] [Related]
5. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice. Hassan ZM; Rees RC; Potter CW Br J Cancer; 1981 Oct; 44(4):532-8. PubMed ID: 7295509 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect between neutrophils and Corynebacterium parvum in the process of macrophage activation. Chapes SK; Haskill S Cancer Res; 1984 Jan; 44(1):31-4. PubMed ID: 6228293 [TBL] [Abstract][Full Text] [Related]
7. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages. Lichtenstein A Cell Immunol; 1985 Sep; 94(2):521-35. PubMed ID: 4028167 [TBL] [Abstract][Full Text] [Related]
8. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells. Campbell MW; Sholley MM; Miller GA Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781 [No Abstract] [Full Text] [Related]
9. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)]. Fray A; Lorinet AM; Thobie N; Halpern B Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346 [TBL] [Abstract][Full Text] [Related]
10. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997 [TBL] [Abstract][Full Text] [Related]
11. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice. Kiya K; Toge T; Harada K; Uozumi T; Hattori T Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201 [TBL] [Abstract][Full Text] [Related]
12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
13. Cytostatic activity of in vitro generated macrophages: evidence for a prostaglandin-independent reversible cytostatic mechanism. Stout RD Cell Immunol; 1985 Nov; 96(1):83-103. PubMed ID: 2424622 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I. Hopper KE; Cahill JM J Reticuloendothel Soc; 1983 Jun; 33(6):443-56. PubMed ID: 6602218 [TBL] [Abstract][Full Text] [Related]
16. Appearance of a cell surface antigen associated with the activation of peritoneal macrophages in mice. Akagawa KS; Tokunaga T Microbiol Immunol; 1982; 26(9):831-42. PubMed ID: 7154991 [TBL] [Abstract][Full Text] [Related]
17. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation. Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463 [TBL] [Abstract][Full Text] [Related]
18. Activation and mechanism of action of suppressor macrophages. Lichtenstein A; Murahata R; Terpenning M; Cantrell J; Zighelboim J Cell Immunol; 1981 Oct; 64(1):150-61. PubMed ID: 6457695 [No Abstract] [Full Text] [Related]
19. Differential sensitivity of two murine leukaemia sublines to cytolysis by Corynebacterium parvum-activated macrophages. Berd D; Mastrangelo MJ Br J Cancer; 1981 Dec; 44(6):819-27. PubMed ID: 7326193 [TBL] [Abstract][Full Text] [Related]
20. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages. Sugawara I; Lee KC; Wong M Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]